title: Nuclear membrane cholesterol can modulate nuclear nucleoside triphosphatase activity.
abstract: Previous work has suggested that changes in nuclear membrane cholesterol may induce a stimulation in nuclear nucleoside triphosphatase (NTPase) activity. The purpose of the present study was to directly investigate if nuclear membrane cholesterol can stimulate nuclear NTPase activity. The cholesterol content of nuclei was altered with a liposomal methodology. The cholesterol content of nuclei isolated from hepatic tissue was relatively low in comparison to that typically exhibited by other membrane fractions. Because of this, it was difficult to further deplete the nuclear membrane of cholesterol, but we could successfully increase the cholesterol content after exposure to cholesterol-enriched liposomes. Nuclear NTPase activity was potently stimulated (approximately 150-200% of control) by an increase in the nuclear membrane cholesterol content. The Vmax of the NTPase activity in the presence of ATP or GTP was significantly increased after cholesterol enrichment without altering the affinity of the enzyme for these moieties. Mg2+ dependency of NTPase activity was also altered by cholesterol incorporation into the nuclear membrane. Cholesterol enrichment of the nuclear membrane also left the nuclei more susceptible to damage by salt-induced lysis than control nuclei. Our results clearly demonstrate that the cholesterol content of the nuclear membrane will have significant, direct effects on nuclear integrity and NTPase activity.
authors.affiliation: Ion Transport Laboratory, St. Boniface General Hospital Research Centre, Winnipeg, Canada.
authors.forename: B
authors.initials: B
authors.lastname: Ramjiawan
authors.forename: M P
authors.initials: MP
authors.lastname: Czubryt
authors.forename: J S
authors.initials: JS
authors.lastname: Gilchrist
authors.forename: G N
authors.initials: GN
authors.lastname: Pierce
mesh_terms: D017766:Acid Anhydride Hydrolases / Q000378:metabolism*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002467:Cell Nucleus / Q000737:chemistry* / Q000378:metabolism*; D002784:Cholesterol / Q000008:administration & dosage* / Q000032:analysis / Q000378:metabolism*; D004337:Drug Carriers; D006160:Guanosine Triphosphate / Q000494:pharmacology; D008081:Liposomes; D008099:Liver / Q000166:cytology*; D008274:Magnesium / Q000378:metabolism; D008297:Male; D009685:Nuclear Envelope / Q000737:chemistry* / Q000378:metabolism*; D043583:Nucleoside-Triphosphatase; D010713:Phosphatidylcholines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012492:Salts / Q000494:pharmacology
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D010713:Phosphatidylcholines; D012492:Salts; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate; D002784:Cholesterol; D017766:Acid Anhydride Hydrolases; D043583:Nucleoside-Triphosphatase; D008274:Magnesium